September 2020 Issue Table Of Contents

From The Editor

• What Can A Conversation On Cars Reveal About A Leader?

Feature Articles

• From Diligence To Execution — Tim Wright’s Approach To Leading MiMedx

Capitol Perspectives

• Trump Threatens Rx Industry With Executive Orders

CEO Corner

• Building a Biotech: The Third Key Ingredient Beyond Innovation & Funding
• Moving From Crisis To Lasting Change

Companies To Watch

• CalciMedica

From Policy to Execution

• The Holy Grail: Bringing A Vaccine To Market … Soon

Industry Research

• Manufacturing Expenditure By Activity

Inside The Industry

• Drug Pricing Reform Twists And Turns In The COVID-19 Era
• 5 Steps To Prepare For A Third-Party Drug Price Evaluation
• Public-Private Partnerships Can Lead To Long-Term Success
• Eyes On Horizon, Buying Into Bio
• How Flexion Pivoted To Become A Commercial Biotech
• What To Know About Patents For Software As A Medical Device

Leadership Lessons

• Creating Positive Connections In The Virtual World

Ask The Board

• What Additional Protocols Have You Observed Being Implemented To Protect Biopharma Manufacturing Employees, And What Impact Do You Anticipate On The Bottom Line From These Added Costs?
• What Are Some Of The Best Business Practices That Didn’t Exist At Your Company Prior To COVID-19 That Will Likely Continue Long After The Pandemic Subsides?
• Given The Success Of Virtual Investor Pitching, Do You Think Events Like JPM And BTS Will Remain Relevant?